Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Winer

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|November 11, 1998
Utility of three-dimensional echocardiography during balloon mitral valvuloplastyR M Applebaum, R R Kasliwal, A Kanojia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancerW P Peters, M Ross, J J Vredenburgh, et al.
Breast Cancer Research and Treatment|February 29, 2008
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)G G Kimmick, C Cirrincione, D B Duggan, et al.
Journal of the American College of Cardiology|April 1, 1991
Comparison of cardiac catheterization and Doppler echocardiography in the decision to operate in aortic and mitral valve diseaseJ Slater, A J Gindea, R S Freedberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumorsJ Balmaña, N M Tung, S J Isakoff, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642M E Costanza, R B Weiss, I C Henderson, et al.
Psycho-Oncology|April 18, 2000
Involving family members in cancer care: focus group considerations of patients and oncological providersJ Speice, J Harkness, H Laneri, et al.
Leukemia|April 5, 2014
Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemiaA Chorzalska, I Salloum, H Shafqat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2021
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysisG Curigliano, V Mueller, V Borges, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|November 11, 1998
Utility of three-dimensional echocardiography during balloon mitral valvuloplastyR M Applebaum, R R Kasliwal, A Kanojia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancerW P Peters, M Ross, J J Vredenburgh, et al.
Breast Cancer Research and Treatment|February 29, 2008
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)G G Kimmick, C Cirrincione, D B Duggan, et al.
Journal of the American College of Cardiology|April 1, 1991
Comparison of cardiac catheterization and Doppler echocardiography in the decision to operate in aortic and mitral valve diseaseJ Slater, A J Gindea, R S Freedberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumorsJ Balmaña, N M Tung, S J Isakoff, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642M E Costanza, R B Weiss, I C Henderson, et al.
Psycho-Oncology|April 18, 2000
Involving family members in cancer care: focus group considerations of patients and oncological providersJ Speice, J Harkness, H Laneri, et al.
Leukemia|April 5, 2014
Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemiaA Chorzalska, I Salloum, H Shafqat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2021
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysisG Curigliano, V Mueller, V Borges, et al.
Pageof 7